A pilot and feasibility randomised controlled study of Prolonged Exposure Treatment and supportive counselling for post-traumatic stress disorder in adolescents: a third world, task-shifting, community-based sample

Table 1 Primary and secondary outcomes at baseline, post treatment, and at 12-month follow-up

	PE-A (n = 6)	SC (n = 5)	Between-treatment differences in improvement from baseline	p value
Primary outcome
Interviewer-rated PTSD (CPSS-I), Mean (95% CI)
Baseline	32.3 (26.5–38.2)	34.8 (28.4–41.2)
Post treatment	2.8 (−3.0–8.7)	10.0 (1.8–18.1)	4.7 (−7.3–17.7)	0.4418
12-month	3.0 (−2.8–8.8)	22.4 (12.3–32.5)	16.9 (2.3–31.6)	0.0234
Secondary outcome
Depression (BDI), mean (95% CI)
Baseline	22.3 (14.5–30.1)	27.6 (19.1–36.1)
Post treatment	2.1 (−5.6–10.0)	4.3 (−6.6–15.2)	−3.2 (−19.6–13.3)	0.7068
12-month	4.7 (−3.1–12.5)	32.7 (19.2–46.2)	22.7 (3.0–42.6)	0.0295

BDI Beck Depression Inventory, CI confidence interval, CPSS-I Child PTSD Symptom Scale–Interview, PE-A Prolonged Exposure Treatment for Adolescents, PTSD post-traumatic stress disorder, SC supportive counselling. Baseline and total sample data reflect the raw means. Means for the treatment conditions at the post treatment assessment and at 12-month follow-up and differences in improvement are taken from the linear mixed model growth curve analyses. The p value is for between-treatment differences in improvement

ISSN: 1745-6215